皓宸医疗
(002622)
| 流通市值：25.54亿 | | | 总市值：25.54亿 |
| 流通股本：8.40亿 | | | 总股本：8.40亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 154,125,521.53 | 130,816,113.68 | 119,306,297.16 | 146,388,361.1 |
| 应收票据及应收账款 | 38,945,614.05 | 37,136,953.5 | 34,800,583.34 | 37,296,995.44 |
| 其中：应收票据 | 11,544,225.63 | 13,646,843.05 | 2,584,312.56 | 5,547,020.71 |
| 应收账款 | 27,401,388.42 | 23,490,110.45 | 32,216,270.78 | 31,749,974.73 |
| 预付款项 | 15,016,494.9 | 17,584,113.5 | 17,477,928.39 | 12,959,242.62 |
| 其他应收款合计 | 42,636,308.72 | 44,047,910.82 | 42,602,188.81 | 41,050,442.15 |
| 应收股利 | 22,700,000 | 22,700,000 | 22,700,000 | 22,700,000 |
| 存货 | 59,474,920.03 | 64,009,052.31 | 72,975,282.09 | 62,143,075.81 |
| 其他流动资产 | 2,122,097.53 | 2,105,858.68 | 1,783,083.18 | 2,234,778.11 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 313,035,141.47 | 296,414,187.2 | 289,659,547.68 | 302,787,079.94 |
| 非流动资产: | | | | |
| 长期股权投资 | 499,532,663.69 | 495,227,662.79 | 486,739,590.13 | 476,480,000 |
| 其他权益工具投资 | 11,800,000 | 11,800,000 | 11,800,000 | 11,800,000 |
| 投资性房地产 | 31,584,972.66 | 31,928,353.08 | 32,271,733.5 | 32,615,113.92 |
| 固定资产 | 163,490,175.39 | 166,262,287 | 168,445,959.63 | 170,827,939 |
| 在建工程 | - | - | - | 79,530.81 |
| 使用权资产 | 185,247,849.44 | 189,766,784.02 | 171,022,565.84 | 178,087,342.8 |
| 无形资产 | 48,263,956.35 | 47,554,001.35 | 47,055,234.2 | 47,795,049.69 |
| 商誉 | 199,672,759.15 | 199,672,759.15 | 199,672,759.15 | 199,672,759.15 |
| 长期待摊费用 | 63,373,020.37 | 64,033,009.76 | 65,664,483.43 | 65,850,399.03 |
| 递延所得税资产 | 49,746,626.45 | 49,599,158.78 | 52,231,854.31 | 49,895,385.23 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,252,712,023.5 | 1,255,844,015.93 | 1,234,904,180.19 | 1,233,103,519.63 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,565,747,164.97 | 1,552,258,203.13 | 1,524,563,727.87 | 1,535,890,599.57 |
| 流动负债: | | | | |
| 短期借款 | 113,528,594.44 | 113,729,175 | 113,759,100 | 120,773,120.69 |
| 应付票据及应付账款 | 71,369,890.97 | 69,626,417.83 | 70,589,137.25 | 60,113,853.34 |
| 应付账款 | 71,369,890.97 | 69,626,417.83 | 70,589,137.25 | 60,113,853.34 |
| 合同负债 | 139,267,140.68 | 152,960,561.63 | 155,882,641.84 | 154,090,483.06 |
| 应付职工薪酬 | 28,737,282.08 | 25,693,020.54 | 25,517,424.41 | 27,553,688.82 |
| 应交税费 | 3,886,099.19 | 3,496,002.28 | 1,967,432.36 | 5,856,335.34 |
| 其他应付款合计 | 313,863,412.58 | 309,429,108.07 | 305,231,713.71 | 302,013,189.53 |
| 其中:应付利息 | 65,171,762.66 | 60,629,767.76 | 56,137,142.38 | 51,644,512.99 |
| 一年内到期的非流动负债 | 221,453,389.48 | 219,647,703 | 219,778,047.85 | 217,892,737.69 |
| 其他流动负债 | 1,241,922.51 | 1,915,397.75 | 1,153,380.27 | 3,463,756.49 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 893,347,731.93 | 896,497,386.1 | 893,878,877.69 | 891,757,164.96 |
| 非流动负债: | | | | |
| 租赁负债 | 163,338,116.8 | 168,834,887.62 | 149,550,046.25 | 161,343,499.43 |
| 递延收益 | 8,773,431.95 | 8,885,179.13 | 8,996,926.31 | 9,108,673.49 |
| 递延所得税负债 | 7,863,151.09 | 8,081,113.77 | 8,353,396.98 | 8,538,301.7 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 179,974,699.84 | 185,801,180.52 | 166,900,369.54 | 178,990,474.62 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,073,322,431.77 | 1,082,298,566.62 | 1,060,779,247.23 | 1,070,747,639.58 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 840,000,000 | 840,000,000 | 840,000,000 | 840,000,000 |
| 资本公积 | 21,685,838.28 | 21,685,838.28 | 21,685,838.28 | 21,685,838.28 |
| 其他综合收益 | -50,057,613.5 | -49,587,133.07 | -50,697,366.87 | -51,597,708.41 |
| 盈余公积 | 40,813,718.28 | 40,813,718.28 | 40,813,718.28 | 40,813,718.28 |
| 未分配利润 | -404,621,157.69 | -417,564,331.89 | -420,259,460.43 | -418,117,817.07 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 447,820,785.37 | 435,348,091.6 | 431,542,729.26 | 432,784,031.08 |
| 少数股东权益 | 44,603,947.83 | 34,611,544.91 | 32,241,751.38 | 32,358,928.91 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 492,424,733.2 | 469,959,636.51 | 463,784,480.64 | 465,142,959.99 |
| 负债和股东权益合计 | 1,565,747,164.97 | 1,552,258,203.13 | 1,524,563,727.87 | 1,535,890,599.57 |
| 公告日期 | 2024-10-31 | 2024-08-30 | 2024-04-29 | 2024-04-29 |
| 审计意见(境内) | | | | 带强调事项段的无保留意见 |